Logo image
LBO-006 Efficacy and safety of volixibat, an IBAT inhibitor, in patients with primary sclerosing cholangitis and moderate-to-severe pruritus: results of the VISTAS trial
Abstract   Peer reviewed

LBO-006 Efficacy and safety of volixibat, an IBAT inhibitor, in patients with primary sclerosing cholangitis and moderate-to-severe pruritus: results of the VISTAS trial

Cynthia Levy, Gideon M. Hirschfield, Mitchell Shiffman, Muyiwa Awoniyi, Deepak Joshi, Debra Weinstein, Douglas Thorburn, Alejandra Villamil, Ynto de Boer, Parvez Mantry, …
Journal of Hepatology, Vol.84(Supplement 1), pp.S10-S11
European Association for the Study of Liver (EASL) Congress, 2026 (Barcelona, Spain, 27-May-2026–30-May-2026)
2026

Abstract

No abstract available.

Details

Metrics

1 Record Views
Logo image